tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed Tools30% OFF!
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ABBV Stock Latest News

AbbVie reports CHMP opinion recommending approval for risankizumab
The FlyAbbVie reports CHMP opinion recommending approval for risankizumab
1d ago
ABBV
AbbVie to present new antitumor data from ADC platform
PremiumThe Fly
AbbVie to present new antitumor data from ADC platform
4d ago
ABBV
AbbVie completes the acquisition of Landos Biopharma
PremiumThe Fly
AbbVie completes the acquisition of Landos Biopharma
9d ago
ABBV
LABP
AbbVie Completes Acquisition of Landos Biopharma
PremiumPress Releases
AbbVie Completes Acquisition of Landos Biopharma
9d ago
ABBV
LABP
Robinhood upgraded, Baidu downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Robinhood upgraded, Baidu downgraded: Wall Street’s top analyst calls
15d ago
DD
DRI
AbbVie initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyAbbVie initiated with an Overweight at Cantor Fitzgerald
15d ago
ABBV
AbbVie initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
AbbVie initiated with an Overweight at Cantor Fitzgerald
15d ago
ABBV
3 Best Value Stocks to Buy in May 2024, According to Analysts
PremiumMarket News
3 Best Value Stocks to Buy in May 2024, According to Analysts
17d ago
T
ABBV
AbbVie, Gilgamesh Pharmaceuticals to co-develop psychiatric disorder therapies
PremiumThe Fly
AbbVie, Gilgamesh Pharmaceuticals to co-develop psychiatric disorder therapies
19d ago
ABBV
Genmab reports Q1 revenue increased 46% vs. last year
PremiumThe Fly
Genmab reports Q1 revenue increased 46% vs. last year
1M ago
JNJ
NVS
AbbVie price target lowered to $180 from $195 at BMO Capital
PremiumThe Fly
AbbVie price target lowered to $180 from $195 at BMO Capital
1M ago
ABBV
AbbVie price target lowered to $191 from $196 at Morgan Stanley
PremiumThe Fly
AbbVie price target lowered to $191 from $196 at Morgan Stanley
1M ago
ABBV
AbbVie price target lowered to $187 from $195 at Barclays
PremiumThe FlyAbbVie price target lowered to $187 from $195 at Barclays
1M ago
ABBV
AbbVie (NYSE:ABBV) Sinks as Humira Drug Sees Increased Competition
PremiumMarket News
AbbVie (NYSE:ABBV) Sinks as Humira Drug Sees Increased Competition
1M ago
ABBV
AbbVie says Humira downdraft ‘within what was assumed’
PremiumThe Fly
AbbVie says Humira downdraft ‘within what was assumed’
1M ago
ABBV
AbbVie sees FY24 revenue approximately $55B, consensus $54.6B
PremiumThe Fly
AbbVie sees FY24 revenue approximately $55B, consensus $54.6B
1M ago
ABBV
AbbVie sees Q2 adjusted EPS $3.05-$3.09, consensus $2.81
PremiumThe Fly
AbbVie sees Q2 adjusted EPS $3.05-$3.09, consensus $2.81
1M ago
ABBV
AbbVie says Q1 results exceeded expectations
PremiumThe Fly
AbbVie says Q1 results exceeded expectations
1M ago
ABBV
AbbVie reports Q1 global revenue from immunology portfolio $5.371B, down 3.9%
PremiumThe Fly
AbbVie reports Q1 global revenue from immunology portfolio $5.371B, down 3.9%
1M ago
ABBV
AbbVie Reports First-Quarter 2024 Financial Results
PremiumPress ReleasesAbbVie Reports First-Quarter 2024 Financial Results
1M ago
ABBV
AbbVie raises FY24 adjusted EPS view to $11.13-$11.33 from $10.97-$11.17
PremiumThe Fly
AbbVie raises FY24 adjusted EPS view to $11.13-$11.33 from $10.97-$11.17
1M ago
ABBV
AbbVie reports Q1 adjusted EPS $2.31, consensus $2.23
PremiumThe Fly
AbbVie reports Q1 adjusted EPS $2.31, consensus $2.23
1M ago
ABBV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >